SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001274173-21-000103
Filing Date
2021-10-12
Accepted
2021-10-12 12:47:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 JANUS HENDERSON GROUP PLC OWNS 10.1% OF GLOBAL BLOOD THERAPEUTICS gbt10102021.txt SC 13G/A 8931
  Complete submission text file 0001274173-21-000103.txt   10630
Mailing Address 201 BISHOPSGATE LONDON X0 EC2M 3AE
Business Address 201 BISHOPSGATE LONDON X0 EC2M 3AE 442078181818
JANUS HENDERSON GROUP PLC (Filed by) CIK: 0001274173 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Subject) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88976 | Film No.: 211318053
SIC: 2834 Pharmaceutical Preparations